29300-132 : Zaleplon 10 mg Oral Capsule


NDC: 29300-132
Labeler: Unichem Pharmaceuticals (Usa), Inc.
Product Type: Human Prescription Drug
Drug Name:  Zaleplon
Dosage Form: Oral Capsule
Application #: ANDA078989
Rev. Date: 
CSA Schedule: CIV (US) [1]


[1] Schedule IV Controlled Substance: Low potential for abuse relative to substances in Schedule III. Examples include Alprazolam (Xanax), Diazepam (Valium), Carisoprodol (Soma), Clonazepam (Klonopin), Lorazepam (Ativan), Clorazepate (Tranxene), Midazolam (Versed), Temazepam (Restoril), and Triazolam (Halcion).. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: U;132
Shapes:  Capsule
Colors:  Blue
Size (mm): 15
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 29300-132-01: 100 CAPSULE IN 1 BOTTLE, PLASTIC (29300‑132‑01)
  • 29300-132-05: 500 CAPSULE IN 1 BOTTLE, PLASTIC (29300‑132‑05)
  • 29300-132-10: 1000 CAPSULE IN 1 BOTTLE, PLASTIC (29300‑132‑10)

Active Ingredients:

  • Zaleplon

Dosage Strength:

  • 10 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Starch, Corn
  • Colloidal Silicon Dioxide
  • Sodium Lauryl Sulfate
  • Magnesium Stearate
  • Lactose Monohydrate
  • Gelatin
  • Titanium Dioxide
  • Fd&c Blue No. 1
  • Fd&c Red No. 40
  • Ferrosoferric Oxide

Pharmaceutical Classes:

  • gamma-Aminobutyric Acid A Receptor Agonist [EPC]
  • GABA A Agonists [MoA]
  • Central Nervous System Depression [PE]

Related Products:

Based on records with the same trade name.
  • 29300-131 Zaleplon 5 mg Oral Capsule by Unichem Pharmaceuticals (Usa), Inc.
  • 0054-0084 Zaleplon 5 mg Oral Capsule by Roxane Laboratories, Inc
  • 0054-0085 Zaleplon 10 mg Oral Capsule by Roxane Laboratories, Inc
  • 0093-5268 Zaleplon 5 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-5269 Zaleplon 10 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0378-6805 Zaleplon 5 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-6810 Zaleplon 10 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0832-0400 Zaleplon 5 mg Oral Capsule by Upsher-smith Laboratories, Inc.
  • 0832-0401 Zaleplon 10 mg Oral Capsule by Upsher-smith Laboratories, Inc.
  • 16714-551 Zaleplon 5 mg Oral Capsule by Northstar Rx LLC
  • 16714-561 Zaleplon 10 mg Oral Capsule by Northstar Rx LLC
  • 21695-105 Zaleplon 10 mg Oral Capsule by Rebel Distributors Corp.
  • 21695-376 Zaleplon 5 mg Oral Capsule by Rebel Distributors Corp.
  • 33261-454 Zaleplon 10 mg/1 Oral Capsule by Aidarex Pharmaceuticals LLC
  • 33261-486 Zaleplon 5 mg/1 Oral Capsule by Aidarex Pharmaceuticals LLC
  • 35356-573 Zaleplon 10 mg Oral Capsule by Lake Erie Medical & Surgical Supply Dba Quality Care Products LLC
  • 35356-656 Zaleplon 10 mg Oral Capsule by Lake Erie Medical & Surgical Supply Dba Quality Care Products LLC
  • 42043-210 Zaleplon 5 mg Oral Capsule by Orchidpharma Inc
  • 42043-211 Zaleplon 10 mg Oral Capsule by Orchidpharma Inc
  • 42254-130 Zaleplon 5 mg Oral Capsule by Rebel Distributors Corp
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 29300-132 QR Code

< Prev: 29300-131Next: 29300-133 >

Related Discussions:

chemistry of zaleplon
all information about production & qc of zaleplon ## Zaleplon (marketed under the brand names Sonata and Starnoc) is... 1 reply
How can I disolve Zaleplon
I want to be able to put a 10 mg cap of Zaleplon in a liquid, drink 1/2 refrigerate and drink the other 1/2 the next nig... 1 reply
zaleplon
sonata...
Starnoc/Zaleplon
Why has Starnoc/Zaleplon been discontinued in Canada?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.